ARTICOLI CON IMPACT FACTORPozzilli P,
Manfrini S, Crino A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M,
Visalli N; IMDIAB group.
Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin
D3 in patients with newly diagnosed type 1 diabetes.
Horm Metab Res.
2005 Nov;37(11):680-3. IF 1.946
Afeltra A, Gentilucci UV, Rabitti C,
Amoroso A, Caricato M, Vadacca M, Valeri S, Zardi EM, Coppola R, Picardi A.
Retroperitoneal
fibrosis and ankylosing spondylitis: which links?
Semin Arthritis Rheum.
2005 Aug;35(1):43-8. IF 3.013
Zardi EM, Picardi A, Afeltra A.
Treatment
of cryptosporidiosis in immunocompromised hosts.
Chemotherapy. 2005
Jul;51(4):193-6. Epub 2005 Jul 6. IF 1.240
Patti G, Mega S, Pasceri
V, Nusca A, Giorgi G, Zardi EM, D'Ambrosio A, Dobrina A, Di Sciascio G.
Interleukin-1
receptor antagonist levels correlate with extent of myocardial loss in patients
with acute myocardial infarction.
Clin Cardiol. 2005 Apr;28(4):193-6.
IF 1.069
Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S,
Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M.
Infliximab reverses
growth hormone resistance associated with inflammatory bowel disease.
Aliment
Pharmacol Ther. 2005 May 1;21(9):1063-71. Erratum in: Aliment Pharmacol Ther.
2005 Jun 1;21(11):1398. IF 3.981
Zardi EM, Zardi DM, Cacciapaglia F,
Dobrina A, Amoroso A, Picardi A, Afeltra A.
Endothelial dysfunction and
activation as an expression of disease: role of prostacyclin analogs.
Int
Immunopharmacol. 2005 Mar;5(3):437-59. IF 1.827
Caccavo D, Rigon A,
Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A.
Anti-lactoferrin
antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
Clin
Rheumatol. 2005 Aug;24(4):381-7. IF 1.154
Ambrosino G, Basso SM, Varotto
S, Zardi E, Picardi A, D'Amico DF.
Isolated hepatocytes versus hepatocyte
spheroids: in vitro culture of rat hepatocytes.
Cell Transplant. 2005;14(6):397-401.
IF 2.497
Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti
G, Picardi A, Manfrini S, Osborn J, Pozzilli P, Buzzetti R.
Residual insulin
secretion at diagnosis of type 1 diabetes is independently associated with both,
age of onset and HLA genotype.
Diabetes Metab Res Rev. 2005 May-Jun;21(3):271-5.
IF 3.133
Zardi EM, Vespasiani Gentilucci U, Picardi A, Ambrosino G,
Fazio VM, Dobrina A, Afeltra A.
Iloprost: an adjunctive approach to chronic
viral hepatitis treatment.
Med Hypotheses. 2005;64(1):46-52. IF. 0.607
ATTI
DI CONGRESSO
Picardi A, Valorani MG, Ciofini O, Manfrini S, D'Avola D, Valente
L, Cappa M, Pozzilli P, IMDIAB Group.
Raised C-reactive protein in recent
onset type 1 diabetes.
65th ADA Annual Meeting, San Diego, CA. USA.
Diabetes 2005; 54 (suppl.1) : 716.
Spoletini M, Petrone A, Galgani
A, Di Cola S, Guglielmi C, Picardi A, Manfrini S, Pozzilli P, Buzzetti R.
Insulin
secretion at diagnosis of type 1 diabetes ia associated with both age of onset
and HLA class II.
65th ADA Annual Meeting, San Diego, CA. USA.
Diabetes
2005; 54 (suppl. 1) : 1130.
Picardi A, Valorani MG, Ciofini O, Manfrini
S, D'Avola D, Valente L, Cappa M, Pozzilli P and Group IMDIAB.
Raised C-reactive
protein in patients with recent onset type 1 diabetes.
XXXI National
Congress of the Italian Society of Endocrinology.
J Endocrinol Invest. 2005;
28 (suppl. 4): 36.
Spoletini M, Petrone A, Galgani A, Di Cola S, Guglielmi
C, Picardi A, Manfrini S, Pozzilli P, Buzzetti R.
Insulin secretion at
diagnosis of type 1 diabetes ia associated with both age of onset and HLA class
II.
XXXI National Congress of the Italian Society of Endocrinology.
J Endocrinol Invest. 2005; 28 (suppl. 4): 36.
Valiante S, Barchetta
I, Calabria M, Leomanni C, Manfrini S, Picardi A, Pozzilli P, Hawa M, Leslie D,
Cavallo MG.
Prevalence of GAD antibody positivity in patients with type
2 diabetes with or without metabolic syndrome.
XXXI National Congress
of the Italian Society of Endocrinology.
J Endocrinol Invest. 2005; 28 (suppl.
4): 27.
Caviglia R, Carotti S, Vespasiani Gentilucci U, Picardi A, Ribolsi
M, Afeltra A, Cicala M.
Anti-tumor necrosis factor alpha reverts growth
hormone resistance associated with inflammatory bowel disease.
XI National
Congress of Digestive Diseases. Genova, Italia Marzo 2005.
Dig Liver Dis 2005;37(S1):
S140.